Using advanced imaging to study multiple aspects of Alzheimer's disease
Simultaneous Multi-Tracer Positron Emission Tomography for Interrogating Molecular Pathways of Neurological Disorders
This study is exploring a new imaging method that uses multiple tracers to get a clearer picture of Alzheimer's disease, helping researchers understand how it progresses and find better ways to diagnose and treat it, all while making sure the imaging is safe and non-invasive for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11044050 on NIH RePORTER |
What this research studies
This research investigates a new imaging technique called simultaneous multi-tracer positron emission tomography (PET) to better understand Alzheimer's disease. By using multiple tracers, the study aims to visualize and quantify various biological processes associated with the disease, such as neuroinflammation and amyloid presence, all in one imaging session. This approach allows for a more comprehensive view of the disease's progression and mechanisms, which could lead to improved diagnosis and treatment strategies. Patients will undergo non-invasive imaging procedures to help researchers gather crucial data about their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those showing early signs of cognitive decline.
Not a fit: Patients with neurological disorders other than Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better-targeted treatments for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for studying neurological disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Foster, Jackson West — Stanford University
- Study coordinator: Foster, Jackson West
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.